Atlas Trials

Bioequivalence Study of Perindopril /Amlodipine/Indapamide 8 mg (10 mg)/2.5 mg/10 mg Tablets in Healthy Volunteers Under Fasting Conditions

Clinical trial NCT05940909 · UNKNOWN

Trial details

NCT number
NCT05940909
Sponsor
Pharmtechnology LLC
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Bioequivalence
Start date
2023-06-24
Primary completion
2023-08-17
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.